A Randomized, Open-label, Multicenter, Parallel-group, Exploratory Study to Evaluate the Efficacy of Intravenous Brivaracetam and Intravenous Phenytoin in Subjects Experiencing Nonconvulsive Electrographic Seizures
Phase of Trial: Phase II
Latest Information Update: 15 Apr 2016
Price : $35 *
At a glance
- Drugs Brivaracetam (Primary) ; Phenytoin
- Indications Seizures
- Focus Therapeutic Use
- Sponsors UCB
- 14 Dec 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 14 Jul 2014 Planned End Date changed from 1 Feb 2016 to 1 Mar 2017 as reported by ClinicalTrials.gov record.
- 05 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.